Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor κB activation in tumour-necrosis-factor-α-treated immature acute-myeloid-leukaemia cells

Biochemical Journal

Volumn 351, Issue 2, 2000, Pages 459-467

  Plo, I ^a   Lautier, D ^a   Levade, T ^a   Sekouri, H ^a   Jaffrezou, J P ^a   Laurent, G ^a   Bettaieb, A ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Diacylglycerol; ERK; Phosphocholine; PI3K; PKC

Indexed keywords

ANTILEUKEMIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; DIACYLGLYCEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME SPECIFICITY; GROWTH INHIBITION; HEMATOPOIESIS; HUMAN; HUMAN CELL; HYDROLYSIS; LEUKEMIA CELL; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL NUCLEUS; DIGLYCERIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; HYDROLYSIS; LEUKEMIA, MYELOCYTIC, ACUTE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHORYLCHOLINE; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034667519     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3510459     Document Type: Article

References (54)

1. TNF-alpha inhibits the further development of committed progenitors while stimulating multipotential progenitors in mouse long-term bone marrow cultures
2. Bifunctional effects of tumor necrosis factor alpha (TNF alpha) on the growth of mature and primitive human hematopoietic progenitors cells: Involvement of p55 and p75 TNF receptors
3. Tumor necrosis factor α stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulo/macrophage colony-stimulating factor
4. Expression and role in growth regulation of turnout necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells
5. Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma
6. In vitro interaction of recombinant tumor necrosis factor α and all-trans-retinoic acid with normal and leukemic hematopoietic cells
7. Cytokine response profiles of human myeloid factor-dependent leukemia cell lines
8. The role of type I and type 11 tumor necrosis factor (TNF) receptors in the ability of TNF-α to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e
9. Opposite effects of tumor necrosis factor α on the sphingomyelin-ceramide pathway in two myeloid leukemia cell lines: Role of transverse sphingomyelin distribution in the plasma membrane
10. Tumor necrosis factor induces rapid production of 1,2-diacylglycerol by a phosphatidylcholine-specific phospholipase C
11. TNF activates NF-κB by phosphatidylcholine-specific phosoholipase C-induced 'acidic' sphingomyelin breakdown
12. Tumor necrosis factor cytotoxicity is associated with phospholipase D activation
13. Sensitization of tumor ceils to tumor necrosis factor action by the protein kinase inhibitor staurosporine
14. Phosphorylcholine: A novel second messenger essential for mitogenic activity of growth factors
15. Phosphatidylcholine breakdown and signal transduction
16. Involvement of phosphatidylcholine-specific phospholipase C in plateletderived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts
17. TNF- and cancer therapyinduced apoptosis: Potentiation by inhibition of NF-κB
18. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling
19. Expression of a dominant-negative mutant inhibitor-κB of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression and tumor growth in vivo
20. An essential role for NF-κB in preventing TNF-α-induced cell death
21. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cells
22. A rapid method of total lipid extraction and purification
23. Isolation and enzymic assay of choline and phosphocholine present in cell extracts with picomole sensitivity
24. Tyrosine phosphorylation of insulin receptor substrate-1 and activation of the PI-3-kinase pathway by glycine-extended gastrin precursors
25. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: Inhibition of a phospholipase C-type reaction
26. The antiviral, antitumoural xanthate D609 is a competitor of phosphatidylcholine-specific phospholipase C
27. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1
28. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate-1 to phosphatidylinositol 3-kinase in T3-L1 adipocytes
29. Involvement of phosphatidylinositol 3'-kinase in stem cell factor-induced phospholipase D activation and arachidonic acid release
30. Evidence for a bifurcation of mitogenic signaling pathway activated by ras and phosphatidylcholine-hydrolysing phospholipase C
31. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis
32. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospbolipase C?
33. Activation of protein kinase C family members by the novel polyphosphoinositides Ptdlns-3,4-P2 and Ptdlns-3,4,5-P3
34. Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate
35. Modulation of the growth of transformed cells by human tumor necrosis-α and interferon-α
36. Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells
37. Effect of interleukin-1, tumor necrosis factor-α and interferon-α on the blast cells of acute myeloblastic leukemia
38. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumour-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts
39. Phospholipase C-mediated hydrolysis of phosphatidylcholine is an important step in PDGF-stimulated DNA synthesis
40. Phosphatidylcholine hydrolysis and c-myc expression are in collaborating mitogenic pathways activated by colony-stimulating factor 1
41. GM-CSF and IL-3 stimulate diacylglycerol generation in murine bone marrow-derived macrophages
42. Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism
43. Interleukin 3 stimulates phosphatidylcholine turnover in a mast/megakaryocyte cell line
44. Human interleukin-3 stimulates a phosphatidylcholine specific phospholipase C and protein kinase C translocation
45. Human IL-3 receptor signaling: Rapid induction of phosphatidylcholine hydrolysis is independent of protein kinase C but dependent on tyrosine phosphorylation in transfected NIH 3T3 cells
46. ATP-dependent choline phosphate-induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and phosphoinositide 3'-kinase through an extracellular site
47. Phosphocholine and sphingosine-1-phosphate synergistically stimulate DNA synthesis by a MAP kinase-dependent mechanism
48. TNFα-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-κB activation
49. Human 55kD receptor for tumor necrosis factor coupled to signal transduction cascades
50. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
51. Programmed cell death induced by ceramide
52. Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes
53. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes
54. A paradigm shift in myelodysplastic syndromes